Tag Archives: Athyrium

Basilea Pharmaceutica Ltd secures non-dilutive refinancing from funds managed by Athyrium Capital Management, LP for its outstanding 2022 convertible bonds

Ad hoc announcement pursuant to Art. 53 LR (PRESS RELEASE) BASEL/ ALLSCHWIL, 7-Sep-2022 — /EuropaWire/ — Basilea Pharmaceutica Ltd (SWX: BSLN), a commercial stage biopharmaceutical company, has announced the company has secured non-dilutive refinancing in the amount of CHF 75 … Read the full press release

Basilea Pharmaceutica Ltd obtient un refinancement non dilutif auprès de fonds gérés par Athyrium Capital Management, LP pour ses obligations convertibles 2022 en circulation

Annonce ad hoc conformément à l’art. 53LR (COMMUNIQUÉ DE PRESSE) BASEL/ ALLSCHWIL, 7-Sep-2022 — /EuropaWire/ — Basilea Pharmaceutica Ltd (SWX : BSLN), une société biopharmaceutique au stade commercial, a annoncé la La société a obtenu un refinancement non dilutif d’un montant … Read the full press release